Cancers We Treat
Our Services
Our Doctors
Our Hospitals
Our Technologies
International Patients
Book an Appointment
Online Consultation
Second Opinion
Cancer Screening
Write to Us
Chat with Us

Targeted Therapy in Hemato-Oncology: A New Hope

Monoclonal Antibodies: These are lab-created immune system proteins designed to bind to specific targets on cancer cells. Once attached, they can mark the cancer cell so the body's immune system can destroy it, or they can directly carry toxins to the cancer cell.
Kinase Inhibitors: Kinases are proteins that relay signals to the cell's control center. In some blood cancers, these kinases become overly active, causing uncontrolled cell growth. Kinase inhibitors block these signals, effectively halting the spread of the cancer.
Apoptosis Inducers: Normal cells have a built-in lifecycle that includes a natural death process called apoptosis. Cancer cells often find ways to avoid this process. Apoptosis-inducing drugs force the cancer cells to undergo this natural death.

Receiving a blood cancer diagnosis often brings a wave of questions and concerns. Patients and their families need clear, reliable information to navigate the complex journey ahead. Fortunately, advancements in medical science continue to improve patient outcomes and provide highly effective treatment options.

No Results Found